CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS

Similar documents
CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol

Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1.

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0

MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE

Hypoglycaemia in Adults with Diabetes Clinical Guideline V5.0. March 2018

CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary.

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary.

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4.

MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate.

METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0

School Hearing Screening Policy

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0

Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0

PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline

Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall

SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE

SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline. 2. The Guidance

Suspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18

Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019

CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0

Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0

CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline

Quality & Safety Committee 17 th August 2017 Agenda item: 6.2

Greater Manchester EUR Policy Statement on: Asymptomatic Gallstones GM Ref: GM061 Version: 0.2 (21 November 2018)

Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018

CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY

Ambulatory Emergency Care Pathways. Painless Obstructive Jaundice

CLINICAL PROCEDURE FOR THE SAFE REMOVAL OF FEMORAL ARTERIAL SHEATHS USING A DIGITAL APPROACH 1. Aim/Purpose of this Guideline

AROMATHERAPY - CLINICAL GUIDELINE FOR MIDWIVES. January 2018

CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline

Osteoblasts (cells which form new bone) Osteoclasts (cells which break down old bone)

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary. Start. End. Key: Na + below normal range ( mmol/L) Symptomatic?

Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018

Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0

SHARED CARE GUIDELINE FOR TREATMENT OF DEMENTIA 1. Aim/Purpose of this Guideline

REFERRAL GUIDELINES: GALLSTONES

SHARED CARE GUIDELINE FOR LITHIUM. 1. Aim/Purpose of this Guideline. 2. The Guidance

MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0

Clinical Guideline for the Management of Pot Operative Atrial Fibrillation

DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4

SHARED CARE GUIDELINE FOR MYCOPHENOLATE MOFETIL FOR RHEUMATOLOGY INDICATIONS 1. Aim/Purpose of this Guideline

Presence of choledocholithiasis in patients undergoing cholecystectomy for mild biliary pancreatitis

CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0

Together, putting patients first

Management of GALLSTONE Disease and GALLBLADDER Pathology December 2017

CLINICAL GUIDELINE FOR THE MANAGEMENT OF INPATIENTS WITH PARKINSON S DISEASE

CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0

The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline V5.0 December 2018

Surveillance proposal consultation document

SHARED CARE GUIDELINE FOR CICLOSPORIN IN DERMATOLOGY. 1. Aim/Purpose of this Guideline. 2. The Guidance

Magnetic Resonance Cholangiopancreatography (MRCP) in a District General Hospital

Title Use of Pre-Operative Tests for Elective Surgery Guideline. Department. Anaesthetics. Comment / Changes / Approval

Gallstones Information Leaflet THE DIGESTIVE SYSTEM. Gutscharity.org.uk

Commissioning Policy Individual Funding Request

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital

CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Management of Gallbladder Disease. Cory Buschmann, MD PGY-5 11/28/2017

Study of post cholecystectomy biliary leakage and its management

Appendix A: Summary of evidence from surveillance

Endoscopic Retrograde Pancreatography and Laparoscopic Cholecystectomy. TEAM 1 Janix M. De Guzman, MD Presentor

Melatonin shared care guideline. Document Title. Corporate: Clinical. Type of document. Brief summary of contents

Management of Gallbladder Disease

ERCP and EUS: What s New and What Should We Do?

Specialised Services Commissioning Policy. CP29: Bariatric Surgery

DISCLAIMER. No Conflict of Interest

What can you expect after your ERCP?

ERCP / PTC Surgical Laparoscopic vs open Timing and order of approach

Early management of complicated gallstones and acute pancreatitis

Figure 2: Post-cholecystectomy biliary-like pain

Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs

Pancreatic Cancer (1 of 5)

Percutaneous Transhepatic Cholangiogram (PTC) and Biliary Drainage UHB is a no smoking Trust

Bile Duct Injury during Lap Chole. Bile Duct Injury during cholecystectomy TOPICS. 1. Prevalence, mechanisms, prevention and diagnosis

A CASE REPORT OF SPONTANEOUS BILOMA - AN ENIGMATIC SURGICAL PROBLEM

Appendix J: Full Health Economics Report

MANAGEMENT OF DIABETES MELLITUS (DM) IN PREGNANCY TYPE 1, TYPE 2 AND GESTATIONAL DIABETES (GDM),CLINICAL GUIDELINE. V1.0

Management of biliary injury after laparoscopic cholecystectomy N. Dayes Kings County Hospital Center & Long Island College Hospital 8/19/2010

Biliary Tract Disease. Emmet Andrews Cork University Hospital 6 th September 2010

Spirometry Clinical Guideline V2.0. May 2018

Percutaneous removal of kidney stone(s): procedurespecific information

Information for Consent Cholecystectomy (Laparoscopic/Open) 膽囊切除術 ( 腹腔鏡 / 開放性 )

Surgical Management of CBD Injury Jin Seok Heo

Cancer of Unknown Primary Service

Admission of a Child/Young Person with Cystic Fibrosis Clinical Guideline V3.0 May 2018

GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT

NO SMOKING POLICY. Organisational

Transcription:

CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of gallstones pathology in adults. It has been benchmarked against national guidelines to provide a detailed guidance of clinical management of gallstones pathology in line with best practice guidelines. This guideline applies to all healthcare professionals involved in the treatment of gallstones pathology. 2. The Guidance The following pathway should be followed. Page 1 of 11

Suspected Gallstones Y Ultrasound + LFTs + Amylase Y YES Amylase 3 normal See PANCREATITIS guidelines N Bile duct dilated AND/OR LFTs deranged YES See SUSPECTED BILE DUCT STONE management pathway N AND Fevers (Temp>38 C) See ACUTE CHOLANGITIS guidelines Pain >24 hours AND/OR raised inflammatory markers N YES See ACUTE CHOLECYSTITIS guidelines See BILIARY COLIC management pathway Page 2 of 11

A) SUSPECTED BILE DUCT STONE Management Pathway Normal LFTs Non-dilated bile ducts Normal LFTs Dilated bile ducts History of abnormal LFTs Non dilated bile ducts Abnormal LFTs Dilated bile ducts MINIMAL risk of CBD stones LOW risk of CBD stones If fevers/rigors see CHOLANGITIS guidelines HIGH risk of CBD stones Laparoscopic cholecystectomy (+/-OTC) Laparoscopic cholecystectomy & OTC (MRCP - see indications below in section 2) MRCP if not fit for surgery or OTC not available CBD stone(s) CBD stone(s) No CBD stone(s) Secure cystic duct Bile duct eploration (See indications below) Pre-op ERCP Lap chole +/- OTC Post-op ERCP Key LFT CBD OTC USS ERCP Liver function tests Common bile duct Intraoperative On-Table Cholangiogram Ultrasound Scan Endoscopic Retrograde Cholangio-Pancreatography Page 3 of 11

B) BILIARY COLIC Management Pathway Diagnosis RUQ pain +/- sweating, vomiting Night time pain Precipitated by fatty meals +/- Jaundice Detailed History & Eamination History of gallstones Medication and drug intake Recent intervention (e.g. ERCP / stent) History of biliary stricture / malignancy Co-morbidities (respiratory, cardiac, diabetes, high BMI Investigations A) FBC, U+Es, LFTs, amylase, CRP B) Upper abdominal ultrasound inpatient or outpatient Management - Patient should be discharged with simple analgesia - Advise a low fat diet - Offer laparoscopic cholecystectomy or upper GI surgery outpatient review pending patient or surgeon decision to operate - If surgery declined or not appropriate, refer back to GP with advice on low fat diet. Page 4 of 11

3. Specific Guidelines Regarding Management 3.1 Ownership Patients admitted acutely with gallstone related disease should be managed by the acute GI surgery team UNLESS a definite diagnosis of acute cholangitis is made, in which case they should be admitted under medical gastroenterology. 3.2 Imaging o Gold standard first line investigation is USS abdomen o MRCP indications:- Persistent LFT derangement and/or CBD dilation on ultrasound where intraoperative cholangiogram not available and bile duct stone suspected. As above where surgery not being considered or patient not fit for surgery. Suspected biliary stricture o On table cholangiogram indications:- History of abnormal LFTs and/or dilated bile ducts 3.3 Biliary Drainage (ERCP +/- Percutaneous Transhepatic Cholangiography) o Indications include:- Common bile duct stone with jaundice where surgery not suitable Common bile duct stone without jaundice where surgery not suitable Suspected or definite acute cholangitis Previous cholecystectomy with retained stone 3.4 On-table Cholangiogram / Intra-Operative Ultrasound o Either procedure, determined by surgeon preference, should be performed on all patients undergoing cholecystectomy with persistent or transient: Normal LFTs and dilated bile ducts, Abnormal LFTs and normal bile ducts or Abnormal LFTs and dilated bile ducts 3.5 Laparoscopic Cholecystectomy & Bile Duct Eploration o Indications include: Dilated CBD >8mm Fit for surgery Surgeon epertise and theatre availability No concurrent cholecystitis, cholangitis or pancreatitis Failed ERCP in presence of above indications Page 5 of 11

3.6 Laparoscopic Cholecystectomy for Biliary Colic o Patients with symptomatic gallstones can be discharged once pain controlled on a low fat diet and with outpatient review or elective surgery planned with an upper GI surgeon. 3.7 References o AUGIS. Pathway for the management of acute gallstone diseases. AUGIS 2015 o NICE. Gallstone disease: diagnosis and initial management. 2014 (CG188) Page 6 of 11

4. Monitoring compliance and effectiveness Element to be All monitored Lead Mr Michael Clarke Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared Patient documentation and Rolling audit Adult gallstones pathology patients who are reviewed by specialist teams. Audit 6 monthly Involved specialties governance committees. Repeated noncompliance to be reported via Dati Hospital Working Group Michael Clarke (Consultant upper GI surgeon) - Chair Mohamed Abdelrahman (ST3 General Surgery) Ian Finlay (Consultant upper GI surgeon) Hyder Hussaini (Consultant gastroenterologist) Bill Stableforth (Consultant gastroenterologist) Madeline Strugnell (Consultant radiologist) Dushyant Shetty (Consultant radiologist) John Hancock (Consultant interventional radiologist) Mike Spivey (Consultant in Intensive Care) Required changes to practice will be identified and actioned within 6 months. A lead member of the team will be identified to take each change forward where appropriate. Lessons learned or changes to practice will be shared with all stakeholders. 5. Equality and Diversity 5.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the 'Equality, Diversity & Human Rights Policy' or the Equality and Diversity website. 5.2. Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendi 2. Page 7 of 11

Appendi 1. Governance Information Document Title Clinical Guideline for Management of Gallstones Pathology in Adults Date Issued/Approved: 23/02/2016 Date Valid From: 23/02/2016 Date Valid To: 23/02/2019 Directorate / Department responsible (author/owner): Mr Michael Clarke (Consultant Upper GI and Bariatric Surgeon) Mr Mohamed Abdelrahman (Upper GI Spr) Contact details: Mr Michael Clarke (01872 252373) This guideline is for the management of gallstones Brief summary of contents pathology in adults. This guideline applies to all healthcare professionals involved in the treatment of gallstones pathology. Suggested Keywords: Gallstones, biliary colic, CBD stone. Target Audience RCHT PCH CFT KCCG Eecutive Director responsible for Policy: Date revised: This document replaces (eact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Name and Post Title of additional signatories Name and Signature of Divisional/Directorate Governance Lead confirming approval by specialty and divisional management meetings Signature of Eecutive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Links to key eternal standards Related Documents: Training Need Identified? Medical Director None Nil Hospital working group Michael Clarke (Consultant upper GI surgeon) Ian Finlay (Consultant upper GI surgeon) Hyder Hussaini (Consultant gastroenterologist) Bill Stableforth (Consultant gastroenterologist) Madeline Strugnell (Consultant radiologist) Dushyant Shetty (Consultant radiologist) John Hancock (Consultant interventional radiologist) Mike Spivey (Consultant in Intensive Care) Divisional Governance Committee Divisional Director Duncan Bliss Not required {Original Copy Signed} Name: {Original Copy Signed} Internet & Intranet Clinical / General Surgery None Nil No Intranet Only Page 8 of 11

Version Control Table Date Version No Summary of Changes Changes Made by (Name and Job Title) 01 09 15 V1.0 Draft for consultation Michael Clarke Consultant Upper GI and Bariatric Surgeon 23 Feb 16 V2.0 Approved for implementation Michael Clarke Consultant Upper GI and Bariatric Surgeon All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of epiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the epress permission of the author or their Line Manager. Page 9 of 11

Appendi 2. Initial Equality Impact Assessment Form Name of Service, strategy, policy or project to be assessed (hereafter referred to as policy) : Clinical Management of Gallstones Pathology in Adults Directorate and service area: General Is this a new or eisting Policy? New Surgery Name of individual completing assessment: Telephone: 01872252373 Mr Michael Clarke 1. Policy Aim* To provide detailed guidance on the clinical management of acute Who is the strategy / cholangitis in line with best practice guidelines. policy/proposal/service function aimed at? 2. Policy Objectives* To provide a consistent approach to the management of gallstones pathology at RCHT sites. To maintain patient safety and improve outcomes for patients eperiencing gallstones pathology whilst inpatients at RCH sites 3. Policy intended Outcomes* 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a) Is consultation required with the workforce, equality groups, local interest groups etc. around this policy? Consistent management of gallstones pathology at RCHT sites. Prompt and safe management of gallstones pathology and follow up care. Audit Dati Reporting Review of nursing/ medical documentation as required All patients who eperience gallstones pathology in hospital at RCHT sites. Yes b) If yes, have these *groups been consulted? C). Please list any groups who have been consulted about this procedure. Yes General surgery team (Audit meeting). Consultants (Radiology, Gastroenterology, Microbiology, Intensive care) Page 10 of 11

7. The Impact Please complete the following table. Are there concerns that the policy could have differential impact on: Equality Strands: Yes No Rationale for Assessment / Eisting Evidence Age Se (male, female, transgender / gender reassignment) Race / Ethnic communities /groups Disability - Learning disability, physical disability, sensory impairment and mental health problems Religion / other beliefs Marriage and civil partnership Pregnancy and maternity Seual Orientation, Biseual, Gay, heteroseual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked Yes in any column above and No consultation or evidence of there being consultation- this ecludes any policies which have been identified as not requiring consultation. or Major service redesign or development 8. Please indicate if a full equality analysis is recommended. No 9. If you are not recommending a Full Impact assessment please eplain why. Signature of policy developer / lead manager / director Michael Clarke, Consultant Upper GI and Bariatric Surgeon Date of completion and submission 23 rd February 2016 Names and signatures of members carrying out the Screening Assessment 1. 2. Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD A summary of the results will be published on the Trust s web site. Signed Date Page 11 of 11